Tuesday, January 3, 2017

UPDATE 3-Inotek's eye drug fails late-stage study, shares sink

* Stock slumps as much as 71 pct

(Adds context, analyst comment; updates share move)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)